Enter assignee name

EPO Patents = 4

Forward Citations = 4

Loading Chart...

6 inventors (with patents filed for the assignee):

Lei Yu (6 out of 27 patents)

Liqing Kang (6 out of 6 patents)

Zhou Yu (6 out of 19 patents)

4. Wei Qi (2 out of 16 patents)

5. Gaowu Lin (2 out of 2 patents)

6. Nan Xu (1 out of 2 patents)

7. Zhou Yu (0 patent)

8. Ronghua Xia (0 patent)

9. Zhou Yu (0 patent)

6 patents: Sort by Forward Citations

1. 11242530 - siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applications (2022-02-08),

2. 11098123 - OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereof (2021-08-24),

3. 11066680 - IL6R block CAR-T transgenic vector for alleviating CRS, preparation method thereof (2021-07-20),

4. 10934357 - Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereof (2021-03-02),

5. 10736920 - PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same (2020-08-11),

6. 10702552 - SiRNA of human IL-6 and recombinant expression CAR-T vector and their construction methods and applications (2020-07-07),

Shanghai Unicar-therapy Bio-medicine Technology Co., Ltd is a leading biotechnology company specializing in the research and development of innovative therapies for cancer treatment. With a focus on CAR-T cell therapy, the company aims to revolutionize the way cancer is treated by harnessing the power of the immune system. Through cutting-edge technology and a dedication to improving patient outcomes, Unicar-therapy is at the forefront of the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#340 in Shanghai

#3,927 in China

Shanghai, China

Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd